Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.ChemoCentryx reports positive results from Phase II diabetic nephropathy trial of CCX140
The trial met its primary endpoint by demonstrating that treatment with 5 mg of CCX140 given orally once daily added to a standard of care regimen (SOC) of
The trial met its primary endpoint by demonstrating that treatment with 5 mg of CCX140 given orally once daily added to a standard of care regimen (SOC) of
This product is the generic version of Hikma Maple Ltd.’s Robaxin®. Mylan received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug
The findings were presented at the 53rd Annual Meeting of the American College of Neuropsychopharmacology (ACNP) held December 7-11 in Phoenix, Arizona. Dasotraline, a new chemical entity discovered
The multi-year research program will evaluate a novel approach to improve the function of the defective protein associated with cystic fibrosis, called CFTR. The program is investigating a
This product is the generic version of LASTACAFT (alcaftadine ophthalmic solution) 0.25%, which is indicated for the prevention of itching associated with allergic conjunctivitis. Wilshire believes that it
The recall is being initiated as a result of two complaints (one per lot) of particulate matter that was identified as a fragment of the frangible from the
Ovarian cancer patients who have no measurable disease following their initial standard surgery and chemotherapy treatments have an unmet need that may be served by the DPX-Survivac therapy.
At the time of analysis, the median duration of response had not been reached with three of five responders on therapy for 11 months or more (range, 15
The Manocept platform serves as the molecular backbone of Navidea’s FDA-approved, activated macrophage-targeting agent, Lymphoseek (technetium Tc 99m tilmanocept) injection. Preclinical data being developed by the Company using
AllStar Health Brands has already received two initial Purchase Orders (POs) from the TapouT gyms. The purchase orders are for the TapouT Muscle Recovery, Topical Pain, TapouT Turbo